ResearchDx Will Be Exhibiting At AMP 2021

ResearchDx will be exhibiting at AMP 2021 . Please visit us at booth #327. Additionally, our Chief Medical Officer Dr. Shelly Gunn will present the abstract: “Identification of a Novel Large F13A1 Intragenic Deletion by Targeted Next Generation Sequencing in a Patient with Factor X111 Deficiency.” Please call us at 760 473 4295 to set […]

Read More

Hemophilia—The Royal Disease

Our CAP/CLIA certified lab, PacificDx is partnered with CHOC (Children’s Hospital of Orange County) to identify rare inherited blood disorders in infants and mothers to improve their quality of life. ____________________________________________________________________________________________________________________________________________________ The last royal family of Russia was speculated to be plagued with the “royal bleeding disease” passed down by Queen Victoria of England who […]

Read More

trio-smart: The New Breathtaking Technology

PacificDX is the only lab certified to run trio-Smart™, a breath test developed by Gemelli™. Along with measuring the standard H2, CH4 and CO2 levels, trio-smart™ is the only BT that also measures hydrogen sulfide. You are at a fancy dinner party wearing your favorite dress. After the delicious meal, you are conversing with an […]

Read More

ResearchDx Partners with Lucid Diagnostics for First DNA Methylation Test for Barrett’s Esophagus

As Lucid Diagnostics’ commercial diagnostic laboratory partner, the new EsoGuard esophageal DNA laboratory-developed test (LDT) was developed and completed CLIA and CAP certification at ResearchDx’s premier molecular laboratory, PacificDx. The first of its kind, this non-invasive DNA test was designed to detect the presence of dysplastic and non-dysplastic Barrett’s Esophagus (BE) and esophageal adenocarcinoma (EAC) […]

Read More

Negative Gluten ID Test Results can ‘Rule Out’ Celiac Disease in High Risk Populations

Brief:  First degree relatives of individuals with celiac disease are at elevated risk for developing a similarly severe gluten intolerance disorder. However, a quick screening test for the genetic alterations responsible for encoding gluten recognition immune receptors can rule out celiac disease risk in these individuals. Developed by Targeted Genomics, the DNA-based, non-invasive Gluten ID […]

Read More

Molecular Medicine Tri-Con Meeting

Irvine, CA — Jan 28, 2020 — ResearchDx will attend the Molecular Medicine Tri-Con Meeting in San Francisco California, March 1–4. Please visit our booth #600, or call us at 866.225.9195 or 949.812.6901 to set up a consultation at the show. 

Read More

Blood-Based Biomarkers Discriminate IBS from IBD with High Degree of Certainty in Patients with Chronic Diarrhea

Brief: Two blood-based biomarkers, cytolethal distending toxin B (CdtB) and anti-vinculin, have been substantively linked with the occurrence of diarrhea-predominant forms of irritable bowel syndrome (IBS). As a result, an ELISA-based diagnostic test developed by Gemelli Biotech is now able to “rule-in” an IBS diagnosis while “ruling-out” irritable bowel disease (IBD) based on elevated biomarker […]

Read More

Association for Molecular Pathology (AMP)

Irvine, CA — July 18, 2019 — ResearchDx will attend the Association of Molecular Pathology (AMP) in Baltimore, Maryland November 7–9, 2019. Please visit our booth #2967, or call us at 866.225.9195 or 949.812.6902 to set up a consultation at the show.    

Read More

Association for Molecular Pathology (AMP)

Irvine, CA — Oct 1, 2018 — ResearchDx will attend the Association of Molecular Pathology (AMP) in San Antonio, Texas, November 1–3, 2018. Please visit booth #602, or call us at 866.225.9195 or 949.812.6901 to set up a consultation at the show.

Read More

Association for Molecular Pathology (AMP)

Irvine, CA — November 7, 2017 — ResearchDx will be at the Association for Molecular Pathology (AMP) in Salt Lake City, Utah, November 16-18, 2017. Please visit us at booth 608 or call us at 866.225.9195 or 949.812.6902 to set up a consultation at the show.

Read More